Literature DB >> 10193371

An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen.

J Temelkovski1, S P Hogan, D P Shepherd, P S Foster, R K Kumar.   

Abstract

BACKGROUND: Existing murine models of asthma lack many of the inflammatory and epithelial changes that are typical of the human disease. Moreover, these models are frequently complicated by allergic alveolitis.
METHODS: High IgE responder BALB/c mice were systemically sensitised to ovalbumin and chronically challenged with low particle mass concentrations of aerosolised ovalbumin. Titres of antiovalbumin IgE in serum were measured at two weekly intervals by enzyme immunoassay, accumulation of inflammatory cells and histopathological abnormalities of the epithelium were quantified morphometrically in the trachea and the lungs, and airway reactivity was assessed by measuring bronchoconstriction following intravenous administration of methacholine.
RESULTS: Mice sensitised by two intraperitoneal injections of ovalbumin developed high titres of IgE antibodies to ovalbumin. Following exposure to low concentrations of aerosolised antigen for up to eight weeks these animals developed a progressive inflammatory response in the airways, characterised by the presence of intraepithelial eosinophils and by infiltration of the lamina propria with lymphoid/mononuclear cells, without associated alveolitis. Goblet cell hyperplasia/metaplasia was induced in the intrapulmonary airways, while epithelial thickening and subepithelial fibrosis were evident following chronic exposure. In parallel, the mice developed increased sensitivity to induction of bronchospasm, as well as increased maximal reactivity. Non-immunised mice exposed to aerosolised ovalbumin had low or absent antiovalbumin IgE and did not exhibit inflammatory or epithelial changes, but developed airway hyperreactivity.
CONCLUSIONS: This experimental model replicates many of the features of human asthma and should facilitate studies of pathogenetic mechanisms and of potential therapeutic agents.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10193371      PMCID: PMC1745083          DOI: 10.1136/thx.53.10.849

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  48 in total

1.  Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma. A 3-D morphometric study.

Authors:  M Ebina; T Takahashi; T Chiba; M Motomiya
Journal:  Am Rev Respir Dis       Date:  1993-09

2.  Regulation of IgE responses to inhaled antigen in mice by antigen-specific gamma delta T cells.

Authors:  C McMenamin; C Pimm; M McKersey; P G Holt
Journal:  Science       Date:  1994-09-23       Impact factor: 47.728

3.  Characterization of a murine model of allergic pulmonary inflammation.

Authors:  T T Kung; H Jones; G K Adams; S P Umland; W Kreutner; R W Egan; R W Chapman; A S Watnick
Journal:  Int Arch Allergy Immunol       Date:  1994-09       Impact factor: 2.749

4.  Attenuation of allergic airway inflammation in IL-4 deficient mice.

Authors:  G G Brusselle; J C Kips; J H Tavernier; J G van der Heyden; C A Cuvelier; R A Pauwels; H Bluethmann
Journal:  Clin Exp Allergy       Date:  1994-01       Impact factor: 5.018

5.  Effect of anti-IL-5 monoclonal antibody on allergic bronchial eosinophilia and airway hyperresponsiveness in mice.

Authors:  H Nagai; S Yamaguchi; N Inagaki; N Tsuruoka; Y Hitoshi; K Takatsu
Journal:  Life Sci       Date:  1993       Impact factor: 5.037

6.  Persistent airway hyperresponsiveness and histologic alterations after chronic antigen challenge in cats.

Authors:  P Padrid; S Snook; T Finucane; P Shiue; P Cozzi; J Solway; A R Leff
Journal:  Am J Respir Crit Care Med       Date:  1995-01       Impact factor: 21.405

Review 7.  Animal models of occupational asthma.

Authors:  M H Karol
Journal:  Eur Respir J       Date:  1994-03       Impact factor: 16.671

8.  Eosinophil recruitment into the respiratory epithelium following antigenic challenge in hyper-IgE mice is accompanied by interleukin 5-dependent bronchial hyperresponsiveness.

Authors:  S Y Eum; S Hailé; J Lefort; M Huerre; B B Vargaftig
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

9.  Phenotype of cells expressing mRNA for TH2-type (interleukin 4 and interleukin 5) and TH1-type (interleukin 2 and interferon gamma) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects.

Authors:  S Ying; S R Durham; C J Corrigan; Q Hamid; A B Kay
Journal:  Am J Respir Cell Mol Biol       Date:  1995-05       Impact factor: 6.914

10.  Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity.

Authors:  D B Corry; H G Folkesson; M L Warnock; D J Erle; M A Matthay; J P Wiener-Kronish; R M Locksley
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

View more
  91 in total

1.  Simvastatin inhibits goblet cell hyperplasia and lung arginase in a mouse model of allergic asthma: a novel treatment for airway remodeling?

Authors:  Amir A Zeki; Jennifer M Bratt; Michelle Rabowsky; Jerold A Last; Nicholas J Kenyon
Journal:  Transl Res       Date:  2010-12       Impact factor: 7.012

2.  Alveolar macrophages stimulate enhanced cytokine production by pulmonary CD4+ T-lymphocytes in an exacerbation of murine chronic asthma.

Authors:  Cristan Herbert; Melissa M Scott; Kim H Scruton; Rylie P Keogh; Kristy C Yuan; Kenneth Hsu; Jessica S Siegle; Nicodemus Tedla; Paul S Foster; Rakesh K Kumar
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

3.  Aldose reductase inhibition suppresses the expression of Th2 cytokines and airway inflammation in ovalbumin-induced asthma in mice.

Authors:  Umesh C S Yadav; Amarjit S Naura; Leopoldo Aguilera-Aguirre; Kota V Ramana; Istvan Boldogh; Sanjiv Sur; Hamid A Boulares; Satish K Srivastava
Journal:  J Immunol       Date:  2009-09-14       Impact factor: 5.422

4.  Vascular endothelial growth factor antagonism restores epithelial barrier dysfunction via affecting zonula occludens proteins.

Authors:  Hasan Yuksel; Ozge Yilmaz; Meral Karaman; Fatih Firinci; Ahmet Turkeli; Esra Toprak Kanik; Sevinc Inan
Journal:  Exp Ther Med       Date:  2015-05-18       Impact factor: 2.447

Review 5.  Aligning mouse models of asthma to human endotypes of disease.

Authors:  Rebecca A Martin; Samantha R Hodgkins; Anne E Dixon; Matthew E Poynter
Journal:  Respirology       Date:  2014-05-09       Impact factor: 6.424

6.  Airway and lung pathology due to mucosal surface dehydration in {beta}-epithelial Na+ channel-overexpressing mice: role of TNF-{alpha} and IL-4R{alpha} signaling, influence of neonatal development, and limited efficacy of glucocorticoid treatment.

Authors:  Alessandra Livraghi; Barbara R Grubb; Elizabeth J Hudson; Kristen J Wilkinson; John K Sheehan; Marcus A Mall; Wanda K O'Neal; Richard C Boucher; Scott H Randell
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

7.  Depletion of CD8+ T cells enhances airway remodelling in a rodent model of asthma.

Authors:  Kimitake Tsuchiya; Susumu Isogai; Meiyo Tamaoka; Naohiko Inase; Takumi Akashi; James G Martin; Yasuyuki Yoshizawa
Journal:  Immunology       Date:  2008-06-17       Impact factor: 7.397

8.  Simvastatin inhibits airway hyperreactivity: implications for the mevalonate pathway and beyond.

Authors:  Amir A Zeki; Lisa Franzi; Jerold Last; Nicholas J Kenyon
Journal:  Am J Respir Crit Care Med       Date:  2009-07-16       Impact factor: 21.405

9.  Selective targeting of CREB-binding protein/β-catenin inhibits growth of and extracellular matrix remodelling by airway smooth muscle.

Authors:  Tim Koopmans; Stijn Crutzen; Mark H Menzen; Andrew J Halayko; Tillie-Louise Hackett; Darryl A Knight; Reinoud Gosens
Journal:  Br J Pharmacol       Date:  2016-10-25       Impact factor: 8.739

Review 10.  Barriers to inhaled gene therapy of obstructive lung diseases: A review.

Authors:  Namho Kim; Gregg A Duncan; Justin Hanes; Jung Soo Suk
Journal:  J Control Release       Date:  2016-05-16       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.